Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
99 100 Next >
FDA Approves First Non-Tobacco Flavored E-Cigarettes By NJOY
Via Benzinga
Exposures Product Safety
Tickers MO
Behind the Music: Micol Bok’s Strategy in Shaping Teo Bok’s International Success
Via Get News
Topics Product Recall
Exposures COVID-19 Legal Product Safety
Sarepta's Expanded FDA Approval For Elevidys Potentially Shaping Future FDA Reviews, Analyst Says
Via Benzinga
Exposures Product Safety
Tickers SRPT
Sarepta Therapeutics Stock Soars on FDA Approval
Via MarketBeat
Exposures Product Safety
Tickers SRPT
FDA Panel Overwhelmingly Rejects MDMA Psychedelic as Mental Health Treatment
Via PRLog
Topics Law Enforcement
Exposures Legal Product Safety
InvestorNewsBreaks – Longeveron Inc.’s (NASDAQ: LGVN) Presentation at Virtual Life Sciences Investor Forum Made Available for Online Viewing
Via Investor Brand Network
Exposures Product Safety
Tickers LGVN
Nvidia CEO Jensen Huang Recalls Billions Of Dollars Of Investments In Deep Learning And The Philosophy Behind It: 'If We Don't Build It, They Can't Come'
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers NVDA
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
Via InvestorPlace
Exposures Product Safety
Tickers RHHBY SRPT
Gilead Sciences Stock Surges on HIV Treatment Trial Success
Via MarketBeat
Exposures Product Safety
Tickers GILD IBB
Laser Photonics Inks Deals With Brokk, Fastenal And ISL To Bring Its Laser Technology To More Markets
Via News Direct
Exposures Product Safety
Tickers LASE
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
Via Benzinga
Exposures Product Safety
Tickers PFE RGNX RHHBY SRPT
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Shares Update on Its AVERSA(TM) Fentanyl Product Development Program
Via Investor Brand Network
Exposures Product Safety
Tickers NTRB
PTC Therapeutics Says FDA Lifts Clinical Hold On Investigational Study In Patients With Rare Weak Nerve Cell Disorder
Via Benzinga
Exposures Product Safety
Tickers PTCT
Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer
Via FinancialNewsMedia
Exposures Product Safety
Tickers ONCY TSX:ONC
New Age Superstar David Arkenstone to Release Epic New Album Quest For The Runestone on July 1
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Personal Hour Brings Pilates Machines with Quality, Affordability, and Passion in America
Via Prodigy
Topics Product Recall
Exposures Legal Product Safety
Alzheimer's Drug Stocks: Investing in Eli Lilly, Biogen, Roche
Via MarketBeat
Exposures Product Safety
Tickers BIIB LLY RHHBY
Leading Realtor in Petaluma, CA, Highlights the Importance of Custom Strategies in Challenging Markets
Via AB Newswire
Topics Economy Product Recall
Exposures Economy Legal Product Safety
What's Going On With Dollar Tree Shares Today?
Via Benzinga
Exposures Product Safety
Tickers DLTR WMT
Intra-Cellular Therapies' Highlights Successful Data From Second Depression Study
Via Benzinga
Exposures Product Safety
Tickers ITCI
Findell Capital Management LLC Releases Comprehensive Research Coverage Report on Nasdaq:ESTA
Via Get News
Exposures Product Safety
Tickers ESTA
Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday?
Via Benzinga
Exposures Product Safety
Tickers ZNTL
FDA Approves Merck's Pneumococcal Vaccine As First Shot Designed For Adults
Via Benzinga
Exposures Product Safety
Tickers MRK PFE
Stellantis Recalls Over 1M Vehicles In US Over Rearview Camera Image Display Issues
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers STLA
Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday?
Via Benzinga
Exposures Product Safety
Tickers BNTX PFE
Discovering the World through Maps: A Q&A with Historic Map Collector Jennifer Baccanello
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for $4.4M, Present at Virtual Life Sciences Investor Forum
Via Investor Brand Network
Exposures Product Safety
Tickers LGVN
Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
Via TheNewswire.com
Exposures Product Safety
Tickers CRDL TSX:CRDL
Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
Via News Direct
Exposures Product Safety
Tickers CRDL TSX:CRDL
FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer
Via Benzinga
Exposures Product Safety
Tickers AZN
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.